Nerve conduit based on HAP/PDLLA/PRGD for peripheral nerve regeneration with sustained release of valproic acid

Fei Wu,Chuanjie Jiao,Yue Yang,Feng Liu,Zhibo Sun
DOI: https://doi.org/10.1002/cbin.11613
IF: 4.473
2021-05-03
Cell Biology International
Abstract:<p>The nerve conduits have been developed for the nerve defect repair. However, no artificial conduits have obtained the comparable results to autografts to bridge the large gaps. A possible reason for this poor performance may be lack of sustainable neurotrophic support for axonal regrowth. Previous studies suggested nanocomposite conduits can be used as a carrier for valproic acid (VPA), a common drug that can produce effects similar to the neurotrophic factors. Here we developed the novel bioabsorbable conduits based on HAP/PDLLA/PRGD with sustained release of VPA. Firstly, the sustained release of VPA in this conduit was examined by HPLC. Then schwann cells (SCs) were treated with the conduit extracts. The cell metabolic activity and proliferation were assayed by MTT and BrdU staining. A 10‐mm segment of rat sciatic nerve was resected and then repaired, respectively, using the VPA‐conduit (group A), the PDLLA conduit (group B), or the autografts (group C). NCVs, CMAPs and histological staining were assayed following the surgery. The cell metabolic activity and proliferation were significantly increased (<i>p</i> &lt; 0.05) by the extracts from VPA‐conduit extract compared to others. NCVs and CMAPs were significantly higher in group A and C than group B (<i>p</i> &lt; 0.05). The nerves density of group A and C was higher than group B. There was no significant difference between group A and C. Taken together, this study suggested the sustained‐release VPA conduit promoted peripheral nerve regeneration that was comparable to the autografts. It holds potential for the future use in nerve regeneration.</p><p>This article is protected by copyright. All rights reserved.</p>
cell biology
What problem does this paper attempt to address?
The problem this paper attempts to address is: In the repair of peripheral nerve injuries, existing artificial nerve conduits cannot achieve the effectiveness of autologous transplantation in the repair of long-distance nerve defects. This may be due to insufficient axonal regeneration caused by a lack of continuous neurotrophic support. To this end, the researchers developed a novel bioabsorbable conduit based on hydroxyapatite/polylactic acid (HAP/PDLLA) and poly{lactic-co-[(glycolic acid)-alt-(lysine)]} (PRGD), and achieved sustained release of valproic acid (VPA) through this conduit to promote peripheral nerve regeneration. Specifically, the main objectives of the study are: 1. To develop a novel bioabsorbable nerve conduit capable of sustained release of VPA. 2. To evaluate the effectiveness of this conduit in promoting peripheral nerve regeneration and functional recovery, particularly in a rat sciatic nerve transection model. 3. To compare the differences in nerve conduction velocities (NCVs), compound muscle action potentials (CMAPs), and histological characteristics between the VPA conduit, autologous transplantation, and the use of PDLLA conduit alone, to verify its efficacy. Through these research objectives, the paper aims to explore a new method to improve the regeneration outcomes after peripheral nerve injury, especially for patients who are not suitable for or cannot undergo autologous transplantation, providing an effective alternative solution.